Published by Coherent Market Insights
Posted on September 20, 2021
5 min readLast updated: February 5, 2026
The Vitreous Tamponades Market is set to grow at a 2.5% CAGR, reaching $92.3M by 2028, driven by advancements in retinal disorder treatments.
Global Vitreous Tamponades Market Overview
Vitreous tamponades are essentials that find extensive application in vitrectomy procedures for vitreous dysfunction, and the healing or reattachment of retina. These are widely used in the treatment of various retinal disorders, such as retinal detachment, diabetic retinopathy, retinitis pigmentosa, retinal degeneration, vascular occlusion, macular hole, epiretinal membrane, macular edema, uveitis, and retinopathy of prematurity.
Statistics:
The global vitreous tamponades market was valued at US$ 76.0 Mn in 2019 and is forecast to reach a value of US$ 92.3 Mn by 2027 at a CAGR of 2.5% between 2020 and 2027.
Vitreous humor is a clear and colorless fluid, around 99% of which is made up of water. It occupies the space between the retina and the lens of the eye, and protects the eye by holding its spherical shape and helps hold the retina in place. In vitreous dysfunction, vitreous gets liquefied and shrinks in size, which eventually leads to visual impairment. As vitreous humor cannot regenerate, the cavity must be filled with substitutes by vitrectomy surgery to treat vitreous dysfunction. They are replaced with artificial substitutes, which closely resembles the native vitreous in both function and structure. The ideal vitreous substitutes should be transparent, biocompatible and elastic. Vitreous substitutes such as semi-fluorinated alkanes tamponades and silicone oil/semi fluorinated alkanes combinations are more superior physically and chemically than conventional gas or liquid tamponades. Natural polymers, hydrogels, transplant/implants, and vitreous regeneration are new vitreous substitutes in that are still undergoing the developmental stage.
Request For Sample Copy Here: https://www.coherentmarketinsights.com/insight/request-sample/1193
Vitreous substitutes are used as intraoperative, as well as postoperative tools for surgical treatment of vitreoretinal diseases. They are used as temporary fillers, permanent fillers, or are used as surgical tools at the time of short intraocular surgeries. According to the data published by the National Center for Biotechnology Information (NCBI) in January 2014, retinal detachment is the most common vision-threatening retinal condition, with an incidence rate of 1 per 10,000 individuals annually, which corresponds to around 8,000 new cases in Germany every single year. Increasing incidences of retinal detachment, ophthalmic conditions, and retinal disease are expected to drive the growth of vitreous tamponades market in near future. However, complications associated with the conventional vitreous substitutes hamper the global vitreous tamponades market growth. The intraocular gases have high risk of elevating intracellular pressure on the surrounding retinal membrane. The widely used silicone oil shows short life cycle and needs to be removed early, due to the complications such as emulsification, band keratopathy, and secondary glaucoma. Heavy silicone oil leads to significant intraocular inflammatory reactions and may cause severe complications than conventional silicone oil. Although polymer appears to be more biocompatible, they biodegrade quickly. Hence, long-term biocompatibility of existing vitreous substitute material and need to develop more suitable materials is expected to replace the existing vitreous humor, in turn, boosting the expansion of the global vitreous tamponades market.
Global Vitreous Tamponades Market Taxonomy
By type:
Quick-filling hydrogels expected to replace the conventional vitreous tamponades in the near future
According to the recent findings by the University of Tokyo, new hydrogel-elastic gel was introduced in the vitreous tamponades market. The new hydrogel is administrated in liquid form behind the retina, which then turns into jellylike substance in just 10 minutes. The conventionally available vitreous substitute such as silicone oil and gas do not mix well with water, and hence, they are not suitable for long term application and require long period for gels formation, thereby making them impractical to use during the surgery. The hydrogels have high water content and composed of similar materials those found in soft tissue of eye. Conventional hydrogels absorb water and swell resulting into pressure on the surrounding retinal tissues, which eventually cause damage. The study carried out on hydrogel implanted rabbits showed no adverse effects even after 410 days of treatment.
Get Flat USD 2000 OFF
Buy-Now this research report: https://www.coherentmarketinsights.com/promo/buynow/1193
Reasons to Purchase this Report:
Current and future of global Cancer Registry Software Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
The unique ability of newly developed hydrogel to transform into gel form in very short period and low polymer concentration makes it suitable for broader applications to treat trauma, tumors, and vitreoretinal disease. Potential development in vitreous substitutes are further expected to drive growth of the vitreous tamponades market in near future.
Global Vitreous Tamponades Market – Competitive Scenario
The major players operating in the global vitreous tamponades market are Alcon, Inc., Carl Zeiss Meditec AG, Fluoron GmbH, D.O.R.C. Dutch Ophthalmic Research Center B.V., AL.CHI.MI.A.SRL, CROMA-PHARMA GmbH, and Valeant Pharmaceuticals International, Inc.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Vitreous Tamponades Growth with Healthy CAGR of 2.5% to reach US$ 92.3 Million till 2028 | Coherent Market Insights appeared first on Gatorledger.
The article discusses the growth of the Vitreous Tamponades Market, focusing on its applications in treating retinal disorders.
Vitreous tamponades are used in vitrectomy procedures to treat retinal disorders such as retinal detachment and diabetic retinopathy.
The market faces challenges like complications with current substitutes and the need for long-term biocompatibility.
Explore more articles in the Research Reports category
